Africa’s biggest generic drug maker, Aspen Pharmacare, said on Thursday that it was intent on carving out a niche market in the US, one of the few remaining territories in which the Durban-based company has yet to make its presence felt in a big way.

Source: Ambitious Aspen targets US market